Plain-English translation of NCT05562791 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This pilot study is testing a new type of imaging scan called 68Gallium PSMA-PET/CT to see if it can better detect cancer that has spread in people with advanced bladder cancer or melanoma. Researchers want to compare this new scan with the standard scans doctors currently use. The goal is to learn whether this scan could help doctors find cancer in places that might be missed by regular imaging.
Current imaging scans don't always find all sites of cancer in patients with advanced bladder cancer or melanoma, which can affect treatment decisions. This new scanning method may be better at detecting where cancer has spread, helping doctors treat patients more effectively.
You likely qualify if…
You likely don't qualify if…
If you have bladder cancer, you will first have a standard PET scan with CT imaging, and then you will have the new 68Gallium PSMA-PET/CT scan. If you have melanoma, you will have the new scan along with standard imaging (either a regular PET scan or CT scan). Both scans are non-invasive imaging procedures where you lie still while the scanner takes pictures of your body. The study involves about 20 patients total across both cancer types.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States